about
Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: a meta-analysis.Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cellsActivation or suppression of the immune response mediators in biliary tract cancer (BTC) patients: a systematic review and meta-analysisCocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma.The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform.Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
P2860
Q35535548-D2D2063B-20E9-4186-B217-120765128A65Q36094595-12E241DD-09AB-431B-B6E9-23536CBA2B0FQ36260577-66D2FB9F-B1D6-4700-A6C3-EB29E94F81C1Q37566921-850615AC-27A6-4691-8831-FF75ED7163ADQ39099794-99E978E2-8B50-4F08-9FEC-AD464B923106Q47917911-42C49323-5EF8-46BB-832C-394B7B30A171Q57115352-363AB804-EE0D-43D7-93FE-F8A83A37C502
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in the management of biliary tract cancers
@en
type
label
Advances in the management of biliary tract cancers
@en
prefLabel
Advances in the management of biliary tract cancers
@en
P2860
P1476
Advances in the management of biliary tract cancers
@en
P2093
Kristen Keon Ciombor
Laura Williams Goff
P2860
P577
2013-01-01T00:00:00Z